Aspen leaps on JSE as suitors offer to buy parts of its business
Interest in its active pharmaceutical ingredients operations, excluding French arm, which generated R6.4bn revenue in financial 2021
09 September 2021 - 16:00
Aspen says it has received two unsolicited offers to buy parts of its global active pharmaceutical ingredients (API) business, which manufacturers active ingredients used in medications. Its share price leapt the most in more than four months.
The manufacturing business has operations in SA, the Netherlands and the US, the company said. The offer excluded a French manufacturing facility that also produces APIs...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
This article is free to read if you sign up or sign in.
If you have already registered or subscribed, please sign in to continue.
Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00.